Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05141357
Title A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer (HBI-8000)
Acronym HBI-8000
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors HUYABIO International, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Western Regional Medical Center Goodyear Arizona 85338 United States Details
CBCC Global Research, Inc at Comprehensive Blood and Cancer Center Bakersfield California 93309 United States Details
Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie Florida 34952 United States Details
Southeastern Regional Medical Center Newnan Georgia 30265 United States Details
Midewestern Regional Medical Center, LLC Zion Illinois 60099 United States Details
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 United States Details
Frederick Health-JMSCI Frederick Maryland 21702 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field